Efficacy and safety of lixisenatide in a predominantly Asian population with type 2 diabetes insufficiently controlled with basal insulin: The GetGoal‐L‐C randomized trial

Những quyển sách tương tự

• Predictors of outcomes in patients with type 2 diabetes in the lixisenatide GetGoal clinical trials
  Bằng: Blonde, Lawrence, et al.
  Được phát hành: (2016)
• Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S
  Bằng: Onishi, Yukiko, et al.
  Được phát hành: (2015)
• Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)*
  Bằng: Seino, Y, et al.
  Được phát hành: (2012)
• Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study
  Bằng: Dailey, George E., et al.
  Được phát hành: (2019)
• Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L)
  Bằng: Riddle, Matthew C., et al.
  Được phát hành: (2013)